Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study

✍ Scribed by C. Leonardi; J.M. Sobell; J.J. Crowley; U. Mrowietz; Y. Bao; P.M. Mulani; Y. Gu; M.M. Okun

• Book ID: 117945736
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 877 KB
• Volume: 167
• Category: Article
• ISSN: 0007-0963
• DOI: 10.1111/j.1365-2133.2012.11041.x